Blab Tech
Ambarellas 90-x Forward-Earnings Valuation Raises Concerns Amid SBC-Driven Growth and Margin Compression
Ambarella Inc. (NASDAQ: AMBA) is trading at a forward price‑to‑earnings ratio of roughly 90, a level that has drawn scrutiny from analysts and investors alike. The high multiple is largely driven by non‑GAAP earnings that exclude substantial stock‑based compensation (SBC) expenses, according to an investment thesis released by a research firm. While the company’s revenue grew 16.8% year‑over‑year in fiscal 2026, margin compression and the dilution effect of SBC have tempered enthusiasm for the stock.
Ambarella designs and manufactures ultra‑high‑definition video compression and image‑processing chips that power a range of edge‑AI applications. Its processors are used in automotive cameras, security systems, and robotics, where they perform visual inference locally rather than sending data to a central data center. The company’s product portfolio includes the CV Series, a line of chips aimed at automotive and industrial customers.
The valuation concern stems from the fact that Ambarella’s reported earnings per share exclude SBC, which represents a significant portion of the company’s total compensation costs. When SBC is added back, the forward earnings figure shrinks, pushing the price‑to‑earnings ratio higher. Analysts note that the company’s gross margin has been under pressure, with the latest quarterly report showing a slight decline compared to the same period a year earlier. The combination of a high multiple, margin compression, and a sizable SBC expense creates a scenario where the stock’s valuation may not be justified by the underlying cash‑generating ability of the business.
In May 2026, Ambarella announced a partnership with Hanwha Vision that will deliver $800 million over a decade. The deal is intended to provide a more predictable revenue stream and to validate the CV Series in the automotive and industrial markets. According to the research thesis, Hanwha’s contribution represents only a mid‑single‑digit percentage of Ambarella’s total revenue, but the contract’s long‑term nature is viewed as a de‑risking event that could support the stock’s valuation.
Despite the revenue boost from Hanwha, margin trends remain a key risk factor. The company’s earnings guidance for the third quarter of fiscal 2026 indicates that gross margins will continue to be influenced by the cost of components and the competitive pricing pressure in the edge‑AI market. Analysts also point out that the SBC program, while attractive to employees, adds a recurring expense that is not reflected in the company’s reported earnings, potentially distorting the true profitability of the business.
Investor sentiment has been mixed. Some market participants see Ambarella’s edge‑AI solutions as a cost‑saving alternative for data centers, while others are wary of the company’s high valuation and the dilution effect of SBC. The research firm’s recommendation is a “Hold,” citing strong top‑line growth and product value but offsetting it with the high multiple, margin pressure, and SBC dilution.
Looking ahead, Ambarella is scheduled to unveil new iterations of its CV Series in the second half of 2026, according to the company’s product roadmap. The company has not yet disclosed any regulatory actions or court proceedings that could materially affect its financial outlook. The primary unresolved issues for investors are the trajectory of gross margins, the impact of SBC on earnings, and whether the Hanwha partnership will translate into sustained revenue growth.
In summary, Ambarella’s 90‑x forward‑earnings multiple is largely a product of SBC‑adjusted earnings. While the company’s revenue growth and strategic partnership with Hanwha provide positive signals, margin compression and the dilution effect of SBC remain significant concerns. Investors will need to monitor the company’s ability to maintain or improve margins and to manage SBC expenses as it continues to expand its edge‑AI product line.
Ambarella designs and manufactures ultra‑high‑definition video compression and image‑processing chips that power a range of edge‑AI applications. Its processors are used in automotive cameras, security systems, and robotics, where they perform visual inference locally rather than sending data to a central data center. The company’s product portfolio includes the CV Series, a line of chips aimed at automotive and industrial customers.
The valuation concern stems from the fact that Ambarella’s reported earnings per share exclude SBC, which represents a significant portion of the company’s total compensation costs. When SBC is added back, the forward earnings figure shrinks, pushing the price‑to‑earnings ratio higher. Analysts note that the company’s gross margin has been under pressure, with the latest quarterly report showing a slight decline compared to the same period a year earlier. The combination of a high multiple, margin compression, and a sizable SBC expense creates a scenario where the stock’s valuation may not be justified by the underlying cash‑generating ability of the business.
In May 2026, Ambarella announced a partnership with Hanwha Vision that will deliver $800 million over a decade. The deal is intended to provide a more predictable revenue stream and to validate the CV Series in the automotive and industrial markets. According to the research thesis, Hanwha’s contribution represents only a mid‑single‑digit percentage of Ambarella’s total revenue, but the contract’s long‑term nature is viewed as a de‑risking event that could support the stock’s valuation.
Despite the revenue boost from Hanwha, margin trends remain a key risk factor. The company’s earnings guidance for the third quarter of fiscal 2026 indicates that gross margins will continue to be influenced by the cost of components and the competitive pricing pressure in the edge‑AI market. Analysts also point out that the SBC program, while attractive to employees, adds a recurring expense that is not reflected in the company’s reported earnings, potentially distorting the true profitability of the business.
Investor sentiment has been mixed. Some market participants see Ambarella’s edge‑AI solutions as a cost‑saving alternative for data centers, while others are wary of the company’s high valuation and the dilution effect of SBC. The research firm’s recommendation is a “Hold,” citing strong top‑line growth and product value but offsetting it with the high multiple, margin pressure, and SBC dilution.
Looking ahead, Ambarella is scheduled to unveil new iterations of its CV Series in the second half of 2026, according to the company’s product roadmap. The company has not yet disclosed any regulatory actions or court proceedings that could materially affect its financial outlook. The primary unresolved issues for investors are the trajectory of gross margins, the impact of SBC on earnings, and whether the Hanwha partnership will translate into sustained revenue growth.
In summary, Ambarella’s 90‑x forward‑earnings multiple is largely a product of SBC‑adjusted earnings. While the company’s revenue growth and strategic partnership with Hanwha provide positive signals, margin compression and the dilution effect of SBC remain significant concerns. Investors will need to monitor the company’s ability to maintain or improve margins and to manage SBC expenses as it continues to expand its edge‑AI product line.
